I

Insight Molecular Diagnostics Inc
D

IMDX

3.49000
USD
0.29
(9.06%)
مغلق
حجم التداول
2,290
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
99,811,505
المقالات

العنوان: Insight Molecular Diagnostics Inc

القطاع: Healthcare
الصناعة: Diagnostics & Research
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.